Cannabinoids and the expanded endocannabinoid system in neurological disorders

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607

Structural and dynamic mechanisms of cannabinoid receptors

Guo, X., Li, F., & Zhang, F. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117568 · Cited by 1

Monoacylglycerol lipase inhibition improves motor function and reduces oxidative stress in hemiparkinsonian mice

Mendoza-Camacho, D. M., Paredes, J. M. V., Flores-Soto, M. E., Martínez-Preciado, A. H., & Tejeda-Martínez, A. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.025 · Cited by 2

Assessment of lipid mediators in the urine of patients with Lyme disease, tick-borne encephalitis and human granulocytic anaplasmosis

Biernacki, M., Skrzydlewska, E., Dobrzyńska, M., Czupryna, P., Adamczuk, J., & Moniuszko-Malinowska, A. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-40464-z · Cited by 1

Endocannabinoids and polyunsaturated fatty acids in early schizophrenia: Changes under antipsychotics and association with the response to treatment

Riahi, A., Lansari, R., Fradj, M. K. B., Flah, W. B., Hkimi, K., Emna, B., Melki, W., & Feki, M. (2026) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2026.102734 · Cited by 1

Valsartan Mitigates LPS-Induced Neuroinflammation and Cognitive Deficits via Modulation of RAS–ECS Crosstalk in Mice

Salama, A., Elgohary, R., & Elesawy, W. H. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05728-9 · Cited by 1

From chain length to cell death: mechanistic basis for ROS-mediated apoptosis induced by saturated fatty acids

Salehi, F., Jamali, T., & Kavoosi, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-42822-3 · Cited by 1

Active Pharmaceutical Ingredients in Medical Cannabis: Manufacturer Profiling, Standardization Challenges, and Technological Compatibility

Vyshnevskа, L., Yaromiy, M. V., Пестун, І. В., Georgiev, K. D., Slavov, I. Z., & Коshovyi, O. (2026) · Scientia Pharmaceutica · doi:10.3390/scipharm94020041 · Cited by 1

Disrupted endocannabinoid signaling contributes to systemic inflammation in acute pancreatitis

Romeu, P. G., Cárdenas‐Jaén, K., de‐Madaria, E., Hernández, J. M., Fluvià, L., Torres‐Ribas, L., Closa, D., & Guillamat‐Prats, R. (2026) · The Journal of Pathology · doi:10.1002/path.70076 · Cited by 1

Autism Spectrum Disorder: Integrating Genetic and Environmental Risk

Kamijo, S., Miwa, H., & Ikeda, K. (2026) · Cells · doi:10.3390/cells15110985 · Cited by 2

Metabolic Responses of Melanocytes and Melanoma Cells to UVA Radiation and Phytocannabinoids Exposure

Biernacki, M., Gieniusz, E., Gęgotek, A., Jaganjac, M., & Skrzydlewska, E. (2026) · Antioxidants · doi:10.3390/antiox15060690 · Cited by 1

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years

Moliterni, C., Caissutti, D., Mandolini, E., Fasciolo, E., Çağlar, T. R., Capozzi, A., Misasi, R., & Candelise, N. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1882543 · Cited by 1

Diet, microbiota, and lipidomics: How fatty acids shape the endocannabinoidome and host metabolism

Petrosino, S., Fontecilla-Escobar, J., Marzo, V. D., & Iannotti, F. A. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2026.101396 · Cited by 2

Gut Microbiota Composition and Plasma Metabolomic Profile Are Associated with Amyloid Pathology and Cognitive Performance in Patients with Mild Cognitive Impairment

Mora-Ortiz, M., Cardelo, M. P., Porras‐Pérez, E., Jiménez, A. S., Ledesma‐Escobar, C. A., Priego‐Capote, F., Conde, C., Agüera, E., Reyes, R. P., Malagón, M. M., et al. (2026) · Nutrients · doi:10.3390/nu18132200 · Cited by 1

Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges

Talar-Śpionek, A., Juszczuk‐Kubiak, E., & Roszko, M. Ł. (2026) · Molecules · doi:10.3390/molecules31132385 · Cited by 1

Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds

Odonkor, C. A., Karpe, D. A., Siddique, M. U., & Abd-Elsayed, A. A. (2026) · Pharmaceuticals · doi:10.3390/ph19081151 · Cited by 1

Cannabinoid type 1 receptor availability imaging in attention-deficit/hyperactivity disorder using [18F]MK-9470 positron emission tomography: study protocol of the CB1-ADHD study

Miederer, I., Schofer, M. L., Ruckes, C., Retz, W., Schreckenberger, M., & Sebastian, A. (2026) · EJNMMI Reports · doi:10.1186/s41824-026-00322-7 · Cited by 1

Treatment of diabetic polyneuropathy

Peltier, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820669-0.00021-9 · Cited by 1

O USO DE DELTA-9-HIDROCANNABINOL (THC) E CANNABIDIOL (CBD) NO TRATAMENTO DA DOENÇA DE ALZHEIMER: UMA REVISÃO INTEGRATIVA

Aragão, J. A., Marassi, P. H. A., Lourenço, B. C., Oliveira, A. C. R., Pizano, A. K. D. R., Aragão, M. E. C. D. S., Aragão, I. C. S., Aragão, F. M. S., & Reis, F. P. (2022) · Editora Científica Digital eBooks · doi:10.37885/210906148 · Cited by 1

Role of Endo-opioid and Endo-cannabinoid Systems in Migraine and Medication-overuse Headache

Hatipoğlu, G., Dora, D. D., Özdem, S., & Dora, B. (2022) · Turkish Journal Of Neurology · doi:10.4274/tnd.2022.35467 · Cited by 1

Sativex® for the treatment of Agitation & Aggression in Alzheimer’s Dementia in UK nursing homes (STAND): Protocol for a feasibility randomised controlled trial

Albertyn, C. P., Johar, I., Creese, B., Young, A. H., Carter, B., Velayudhan, L., Bhattacharyya, S., Silva, M. V. D., Samsi, K., Jafari, H., et al. (2023) · Health Open Research · doi:10.12688/healthopenres.13311.1 · Cited by 1

Interplay between endocannabinoid and endovanilloid mechanisms in fear conditioning

Briânis, R. C., Andreotti, J. P., Moreira, F. A., & Iglesias, L. P. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.54 · Cited by 1

Neurotoxicity and neuroprotection induced by plant-derived cannabinoids

Silva, M. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00071-3 · Cited by 1

Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System

Eymery, M., Boumendjel, A., McCarthy, A. A., & Hausmann, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063212 · Cited by 1

Levantamento do uso terapêutico do canabidiol por veterinários na região metropolitana de Belém do Pará

COSTA, A. Í. D. C., Silva, A., Tavares, H., Machado, L., & Pereira, R. (2024) · PubVet · doi:10.31533/pubvet.v18n04e1582 · Cited by 1

Cannabis medicine for chronic pain

Jessen, M. H., Petersen, M., & Leutscher, P. D. C. (2024) · Ugeskrift for Læger · doi:10.61409/v08230546 · Cited by 1

The Synthetic Cannabinoids

Keski, C. (2024) · Eurasian Journal of Toxicology · doi:10.51262/ejtox.1463809 · Cited by 1

Cannabidiol in experimental cerebral ischemia

de Oliveira, R. M. W., Kohara, N. A. N., & Milani, H. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.012 · Cited by 1

Exploratory survey study on adjunctive use of medical cannabis for Gaucher disease

Berman, Y., Ely, R., Scher, Y. Y., & Weinreb, N. J. (2024) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2024.17 · Cited by 1

Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe

Kosar, M., Perera, T., Ganzoni, R. L. Z., Sarott, R. C., Borrega‐Roman, L., Vitale, R. M., Ligresti, A., Rufer, A. C., Guba, W., Grether, U., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202421885 · Cited by 1

Predictors of medical and non-medical motives of cannabis use in Finland: A cross-sectional survey study

Hupli, A., Ünlü, A., Hagfors, H., & Jylkkä, J. (2025) · iScience · doi:10.1016/j.isci.2025.112503 · Cited by 1

Therapeutic Potential and Challenges of Cannabis sativa in Neurological Disorders: Pathways to Integration into Health Systems

de Aquino, P. E. A., Xavier, J. M. C., Fonteles, M. M. D. F., Leal, L. K. A. M., & Viana, G. S. D. B. (2025) · Revista Brasileira de Plantas Medicinais · doi:10.70151/np6wdt13 · Cited by 8

Endocannabinoids and Alzheimer's disease

Chen, C. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00026-8 · Cited by 1

The endocannabinoid system in autism spectrum disorder

Costello, J. A., & Roche, M. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00018-9 · Cited by 1

Clarity on Cannabinoid-Based Products in Medicine

Maldonado, R. J., Centonze, D., & Müller‐Vahl, K. (2021) · EMJ Neurology · doi:10.33590/emjneurol/21-07-suppl-3 · Cited by 1

Neuroimaging Biomarkers for Huntington’s Disease

van de Zande, N. A., Ghariq, E., de Bresser, J., & de Bot, S. T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102528 · Cited by 1

Pharmaceutical Applications of Hemp

Shields, C. M., & Kirk, R. D. (2022) · Springer eBooks · doi:10.1007/978-3-031-05144-9_5 · Cited by 1

Cannabidiol in traumatic brain injury

Palazzo, E., Iannotta, M., Belardo, C., Infantino, R., Ricciardi, F., Boccella, S., Guida, F., Luongo, L., & Maione, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00032-4 · Cited by 1

Cannabinoid Neurobiology and Medical Cannabis Intervention for Amyotrophic Lateral Sclerosis (ALS)

Uzair, M., Qaiser, H., Arshad, M., Zafar, A., & Bashir, S. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch006 · Cited by 1

Endocannabinoid system: An untold story in hypertensive nephropathy

Ahmad, A. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/13055 · Cited by 2

Novel putative ligands of cannabinoid receptors: synthesis and effects on cell signaling and neuronal functions

Senkiv, J., Kryshchyshyn‐Dylevych, A., Khyluk, D., Wujec, M., Stoika, R. S., Irving, A. J., & Lesyk, R. (2023) · The Ukrainian Biochemical Journal · doi:10.15407/ubj95.01.031 · Cited by 1

Medical use of cannabidiol in fragile X syndrome

Johnson, D., & Hagerman, R. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00029-6 · Cited by 1

Cannabinoids in periodontal disease amid the COVID-19 pandemic

Park, J., Jung, K., & Piomelli, D. (2020) · Journal of Periodontal & Implant Science · doi:10.5051/jpis.205006edi01 · Cited by 1

Commentary on “Cannabinoids for Agitation in Alzheimer's Disease”

Goveas, J. S. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.03.004 · Cited by 1

Cannabinoids differentially modulate behavioral and developmental responses to ethanol in DrosophilaPreprint

He, J., Ng, S. Y., Tan, A. M. X., Yong, W. L., & Yu, F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.14.456340 · Cited by 1

Whole-Genome Resequencing of Wild and Cultivated Cannabis Reveals the Genetic Structure and Adaptive Selection of Important TraitsPreprint

Chen, X., Guo, H., Zhang, Q.-Y., Wang, L., Guo, R., Zhan, Y.-X., Lv, P., Xu, Y., Guo, M., Zhang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1135527/v1 · Cited by 1

A GPCR-based yeast biosensor for biomedical, biotechnological, and point-of-use cannabinoid determinationPreprint

Miettinen, K., Leelahakorn, N., Almeida, A., Zhao, Y., Hansen, L., Nikolajsen, I. E., Andersen, J. B., Givskov, M., Stærk, D., Bak, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-743436/v1 · Cited by 1

Pain in psoriatic arthritis and hand osteoarthritis

Vela, J. (2021) · doi:10.54337/aau460188407 · Cited by 1

Cannabis-based medicinal products: a clinical guide

Philips, E., Erridge, S., & Sodergren, M. H. (2022) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2022.18.4.170 · Cited by 1

Roadmap For The Expression Of Canonical and Extended Endocannabinoid System Receptors and Proteins in Peripheral Organs of Preclinical Animal ModelsPreprint

Rosado‐Franco, J. J., Ellison, A. L., White, C., Price, A., Moore, C. F., Williams, R., Fridman, L., Weerts, E. M., & Williams, D. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.10.544455 · Cited by 1

Differential Serum Metabolomic Profile in Patients with Schizophrenia, Cannabis Use Disorder or Dual diagnosisPreprint

Urigüen, L., Villate, A., Olivares, M., Usobiaga, A., Unzueta‐Larrinaga, P., Barrena-Barbadillo, R., Callado, L. F., & Etxebarría, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3410283/v1 · Cited by 1

Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label studyPreprint

El-Sukkari, D., Sharma, K., Fleiss, B., Braganza, D. L., Crichton, A. J., & Fahey, M. C. (2023) · medRxiv · doi:10.1101/2023.12.05.23299505 · Cited by 1

Análise crítica dos efeitos biológicos da fosfoetanolamina sintética no câncer

Rossini, G. A. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-02022024-180840 · Cited by 1

Oral cannabidiol administration in mice during pregnancy and lactation affects early postnatal body weight, fasting glucose, ingestive behavior, anxiety- and obsessive compulsive-like behaviors, and long-term object-memory in adult offspring in a sex-dependent mannerPreprint

Compagno, M. Z. K., Silver, C. R., Cox-Holmes, A. N., Basso, K. B. G., Bishop, C., Bernstein, A. M., Carley, A., Cazorla, J., Claydon, J., Crane, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602955 · Cited by 1

Commentary on the Role of Medicinal Cannabis in Healthy Aging and Neuroprotection

Salas, S. R., Musso, F., & Pascual, A. C. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673375813250305042531 · Cited by 1

Neurodegenerative Diseases: Pathogenesis and Preclinical Models for Translational Drug Discovery

Fusaro, L., Bangari, D. S., Pasterkamp, R. J., Fernández‐Ruíz, J., Youssef, S. A., & Sharma, A. K. (2025) · Toxicologic Pathology · doi:10.1177/01926233251339105 · Cited by 1

Activation of cannabinoid receptor CB1 leads to aberrant myelination in developmentPreprint

Miramontes, T. G., Hamling, K. R., Doan, R. A., Singh, S., Collins, H. Y., Emery, B., Call, C. L., & Monk, K. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693544 · Cited by 1

Cannabis in der Neurologie

Block, F. (2020) · DGNeurologie · doi:10.1007/s42451-020-00152-2

Long-lasting reduction of intrinsic excitability in O-LM interneurons is mediated by endocannabinoid-dependent up-regulation of Kv7 channelsPreprint

Incontro, S., Sammari, M., Ankri, N., Russier, M., Fantini, J., & Debanne, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.08.426009

IMMUNOHISTOCHEMICAL CHARACTERIZATION OF A NOVEL POPULATION OF RETICULAR THALAMIC NEURONS EXPRESSING CHOLECYSTOKININ AND TYPE 1 CANNABINOID RECEPTORS

Mallat, S. (2020) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)

État de l’art et intérêt des dosages plasmatiques des substances endocannabinoïdes et endocannabinoïdes-like

Gish, A., Wiart, J., Turpin, É., Allorge, D., & Gaulier, J. (2021) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2021.07.004

Behavioural and molecular effects induced by Cannabidiol in animal models of depression

Silote, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2021.tde-29092021-060118

The effects of Cannabis sativa extracts on human macrophages in vitro

Zaiachuk, M. (2021)

Insights into the Molecular Role of Endocannabinoids in Diabetes Mellitus

(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac121.470485

Неканоническая активность эндоканнабиноидов и их рецепторов в центральных и периферических синапсах

Balezina, O. P., Tarasova, E. O., & Гайдуков, А. Е. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521070010

Faculty Opinions recommendation of K+ Channels in Primary Afferents and Their Role in Nerve Injury-Induced Pain.

Devor, M. G. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739742122.793583777

Medical Cannabinoid in Pain Management after Spinal Cord Injury

Ri, S., & Kang, I. (2021) · Nursing & Primary Care · doi:10.33425/2639-9474.1188

Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injuryPreprint

Jiang, L., Li, L., Luo, Q., Shang, B., Yang, X., Zhou, J., Pan, Q., Wu, N., Tang, W., Du, D., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-286920/v2

Biogenic Synthesis and characterization of Zinc oxide Nanoparticles by Using Green Machinery: Antibacterial and Antibiofilm potential

Mishra, P., Bano, N., & Ansari, I. A. (2022) · Journal of Ecophysiology and Occupational Health · doi:10.18311/jeoh/2022/29338

Physical Exercise Improved P2Y12-Regulated Microglial Dynamics and Protected Against Ischemic Stroke in the Brain via Endocannabinoid SignalingPreprint

He, X., Zhao, Y., Li, G., Luo, J., Xu, J., Zheng, H., Zhang, L., & Hu, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4072048

Selective Activation of Cannabinoid Receptor-2 Reduces White Matter Injury via Perk Signaling in a Rat Model of Traumatic Brain InjuryPreprint

jiang, L., Li, L., Luo, Q., Shang, B., Yang, X., Zhou, J., Pan, Q., Wu, N., Tang, W., Sun, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-286920/v1

Neurotransmitters, neuromodulators, synapses

Smith, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821913-3.00008-1

A utilização medicinal do THC na doença de Alzheimer/The medicinal use of THC in Alzheimer's disease

Xavier, E. P. M., Lobão, L. H. L. B., Camara, P. H. Z., Napoli, A. L. G., Pacheco, M. C. S., Santos, H. D. C. E., de Oliveira, D. V., & Pacheco, L. M. S. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n3-212

Linking medicinal cannabis to autotaxin-lysophosphatic acid signalingPreprint

Eymery, M., McCarthy, A. A., & Hausmann, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.01.498446

CHOROBA ALZHEIMERA JAKO PRZYK�AD DESYNCHRONIZACJI FUNKCJONOWANIA I ZBI�R NEUROKOGNITYWNYCH WZORC�W STANOWI�CYCH POTENCJALNE �R�D�O ZASOB�W DLA ROZWOJU SZTUCZNEJ INTELIGENCJI

Kaszyńska, A. A. (2022) · Studia Humanistyczne/Studia Humanistyczne AGH · doi:10.7494/human.2022.21.1.23

Developmental but not Adult Exposure to Direct and Indirect CB1 Agonists Persistently Alter Adult Cocaine Reinforcement in Contrasting WaysPreprint

Aldhafiri, A., Dodu, J. C., Alalawi, A. M., & Soderstrom, K. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4104023

OS FITOCANABINOIDES COMO ALTERNATIVA PARA O TRATAMENTO DE DOENÇAS NEUROLÓGICAS: UMA REVISÃO INTEGRATIVA

da Rocha, V. F., & da Silva, J. G. (2022) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-5854-677-1/70-87

Use of cannabidiol in the treatment of patients affected by cerebrovascular accident

Rosa, R. D. S. D., Neves, A. C. F., & Ferreira, P. H. M. (2022) · International Journal of Health Science · doi:10.22533/at.ed.1592382214071

Synthetic Cannabinoids and Neurodevelopment

Silva, J. P., Carmo, H., & Carvalho, F. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_67-1

Cross-tissue multiomics reveals that Akkermansia muciniphila counteracts metabolic syndrome by reprograming gut microbiota, oleoylethanolamide and the gut-hypothalamus axisPreprint

Ha, S. M., Ahn, I., Kowal, T., Yoon, J. G., Olson, C. A., Diamante, G., Cely, I., Zhang, G., Wang, S., Garcia, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.06.506855

USO DA CANNABIS SATIVA NO TRATAMENTO DO CÂNCER DE MAMA

Borges, F. E. D. S., Morais, T. D. S., Silva, H. D., Silva, W. A. N. D., Gomes, L. N., & Borges, F. E. D. S. (2022) · Brazilian Journal of Case Reports · doi:10.52600/2763-583x.bjcr.2022.2.suppl.3.332-337

Editorial: Methods and applications in addiction psychiatry research: 2021

Colizzi, M., & Gregorio, D. D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1063269

Modulação da atividade encefálica pelo canabidiol em camundongos tratados com cocaína

Spelta, L. E. W. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2022.tde-01122022-181624

Fibromyalgia in the light of different methods of treatment

Szota, M., Modlińska, A., Rogacka, K., & Kędziora–Kornatowska, K. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.12.050

Synthetic Cannabinoids and Neurodevelopment

Silva, J. P., Carmo, H., & Carvalho, F. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_67

The Endocannabinoid System in the Central Nervous System: Emphasis on the Role of the Mitochondrial Cannabinoid Receptor 1 (mtCB1R)

Maya-López, M., Zazueta, C., Retana‐Márquez, S., Ali, S. F., Karasu, Ç., Onaivi, E. S., Aschner, M., & Santamarı́a, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_461

Effects of an intervention on adolescents with overweight / obesity

Rossini, G. A., Iyusuka, A. M. L. P., & Maria, D. A. (2022) · International Journal of Family & Community Medicine · doi:10.15406/ijfcm.2022.06.00278

PPAR-γ is a promising therapeutic target for memory deficits induced by early alcohol exposurePreprint

García-Baos, A., Pastor, A., Gallego‐Landin, I., de la Torre, R., Sanz, F., & Valverde, O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.20.524912

Developmental treatments with Δ9- tetrahydrocannabinol and the MAGL inhibitor JZL184 persistently alter adult cocaine conditioning in contrasting ways

Aldhafiri, A. J., Dodu, J. C., Alalawi, A. M., & Soderstrom, K. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173524

El uso terapéutico del cannabis y los cannabinoides

Silva, J. P., & Carvalho, F. D. (2022) · Revista Española de Drogodependencias · doi:10.54108/10031

Effect of Betulinic Acid Nanoparticles Activating CB2 Receptor on Microglial Polarization in Ischemic Brain InjuryPreprint

Guo, Y., Tian, Q., Zhang, Z., Liu, C., Li, Y., Zhu, X., Wang, G., He, P., Wang, J., Chen, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3054119/v1

The Functional Compounds of Cannabis sativa

Hajirahimkhan, S., Hefferon, K. L., & Jackowetz, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823960-5.00044-5

Exercise Improved P2Y12-Regulated Microglial Dynamics During Stroke Via Endocannabinoid SignalingPreprint

He, X., Zhao, Y., Li, G., Luo, J., Xu, J., Zheng, H., Zhang, L., & Hu, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.24.538065

The FAAH inhibitor URB597 reduces cocaine seeking during conditioned punishment and withdrawalPreprint

Alegre-Zurano, L., García-Baos, A., Castro‐Zavala, A., Martín‐Sánchez, A., Medrano, M., Gallego‐Landin, I., & Valverde, O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.13.532386

Substance Use and Substance Use Disorders

Sher, K. J., Conlin, W. E., & Pihl, R. O. (2023) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197542521.003.0013

Die Rolle des Endocannabinoidsystems bei der Borderline-Persönlichkeitsstörung

Kulakova, E., & Wingenfeld, K. (2023) · Nervenheilkunde · doi:10.1055/a-1953-2643

Medical cannabis and neurological disorders: a clinical overview

Erridge, S., & Sodergren, M. H. (2023) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2023.19.sup3.s30

Exercise and Parkinson’s disease: Linking in the cannabinoid type 1 (CB1) and type 2 (CB2) and mu-opioid receptors

Chacur, M., Binda, K. H., & Real, C. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00028-0

Plasma membrane localization of endocannabinoids system receptors

Mahabadi, H. M., & Taghibiglou, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00001-2

Proteomic analysis of cannabinoids in human oligodendrocyte cells

de Almeida, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00047-7

Adenosine A2A-cannabinoid CB1 receptor heteromers in the brain: From trans-inhibition to trans-activation

Aso, E., & Ciruela, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00042-5

Endocannabinoidome and its role in neurological disorders-A comprehensive update of existing literature

Dutta, R. (2021) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001049 · Cited by 1

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders

Estrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 33

Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience

Hassanzadeh, P. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.15030 · Cited by 3

Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2001) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.5.3.349 · Cited by 4

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies

Duncan, R. S., Riordan, S. M., Gernon, M. C., & Koulen, P. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382220 · Cited by 30